Expectations trend
FY2027 · fiscal year ending 2027-12-31 · fmp
Quaker Chemical Corporation (KWR)
NYSEMaterialsChemicals - SpecialtySnapshot 2026-11-04
$152.54-3.03%
Close 2026-11-05 · 1-day change
NYSEMaterialsChemicals - SpecialtySnapshot 2026-11-04
The long-term thesis, the evidence coming in, and the environment around it. Thesis dated Jul 8, 2026.
Next-FY EPS estimate change · 30 days
9.53 → 9.51 EPS · FY ending Dec 31, 2027 · 5 analysts
One observable signal. This measures changing earnings expectations, not the probability of a gain or loss.
Change in the same fiscal period’s mean EPS estimate from Oct 5, 2026 to Nov 4, 2026: (new ÷ prior − 1). Contributor count changed from 5 to 5; this is not the number of analysts revising. The ±10% axis is a display range.
The EPS and P/E reference is not available for KWR yet.
| Measure / period | Management expectations | Analyst expectations |
|---|
Management figures unavailable.
Current consensus figures unavailable.
Three published thesis conditions, with dated milestones shown separately.
| Key Factor | Why It Matters | Current Status | Break Condition | Latest Evidence |
|---|---|---|---|---|
Gross profit margin improvement with at least $15 million increase next four quarters | Gross profit rose $15 million last year. | Intact | Gross profit increase falls below $15 million next year | Gross profit: $193.523M FY2026-Q3; GAAP. Published target: >= $15 million gross profit increase. Target period is not explicitly aligned with this observation. Oct 29, 2026193,523,000 USD · source valueLast status assessment Nov 4, 2026Compare required operating outcomesCompare scope, accounting basis and period before treating this evidence as progress against an annual requirement. |
Compare these dated observations with the operating requirements above
FY2027 · fiscal year ending 2027-12-31 · fmp
The evidence, the remaining questions, and what comes next
No recovery evidence is reported in the available driver assessments.
Next earnings date unavailable
Observed price history; separate from operating scenarios
The weekly editorial context below is a separate assessment from the dated monitor evidence above. Recovery observations do not automatically change the published thesis. Unverified outside influences are hypotheses, not measured driver evidence.
KWR is a growth-and-execution story in a Materials sector with a supportive backdrop. Its long-term thesis is intact, but momentum weakened after the latest earnings miss, and management is rated volatile.
Valuation is about 21% above peers, which points to a premium rather than a cheap valuation. Expectations appear broadly aligned with the business outlook, with only a modest gap, but confidence in that assessment is low.
Over the multi-year view, revenue growth, higher sales volumes, and rising adjusted EBITDA support continued execution on growth priorities. Near term, the recent earnings miss and a run of misses across the company and its peers make guidance and results important risks; savings progress is also not yet quantified against the program target.
The thesis depends on KWR maintaining new business wins and improving operating results while showing measurable progress on cost savings. Near term, a guidance cut would be a meaningful negative, while continued strong results and higher guidance from Materials bellwethers could support the sector backdrop; misses or lower guidance from those peers could weaken it.
For the next 1 to 3 years, KWR’s growth record and recent operating improvement keep the long-term thesis intact, but the latest miss, weaker momentum, and limited evidence on realized savings call for attention to execution. Not investment advice.
Not investment advice. Scores describe historical and current data; they are not forecasts of future returns. Consult a licensed advisor before making investment decisions.
| Cash flow from operations improved to $3.8 million in Q1. |
| Intact |
| Operating cash flow falls below $3.8 million next year |
Direct metric needs a verified mapping The published measure or accounting basis is not supported by an exact source binding. Date unavailableLast status assessment Nov 4, 2026Compare required operating outcomesCompare scope, accounting basis and period before treating this evidence as progress against an annual requirement. |
Year-over-year revenue growth of at least 6% next four quarters | A primary condition in Quaker Chemical Corporation's published investment case. The stated target is >=6% YoY revenue growth. | Intact | YoY revenue growth falls below 6% next year | Revenue growth: 10.27% FY2026-Q3; GAAP. Published target: >=6% YoY revenue growth. Target period is not explicitly aligned with this observation. Oct 29, 202610.267656 percent · calculatedLast status assessment Nov 4, 2026Compare required operating outcomesCompare scope, accounting basis and period before treating this evidence as progress against an annual requirement. |
Stored thesis · Jul 8, 2026. Latest Evidence uses source-matched measurements where available, alongside the last thesis-monitor assessment. Source periods and assessment dates are shown separately. A new measurement does not automatically change the published status or verify an older target.
$8.76 → $9.51 · observed estimates
$2.08B → $2.15B · observed estimates
One fiscal period and provider throughout. At least five contributors are required for each plotted metric; missing coverage stays a gap. Axes show the observed range. Counts measure coverage, not revisions.
| Snapshot | EPS | Revenue | EPS / revenue analysts |
|---|---|---|---|
| 2026-07-24 | $8.76 | $2,081,781,370 | 7 / 7 |
| 2026-07-25 | $8.76 | $2,081,748,145 | 4 / 6 |
| 2026-07-26 | $8.76 | $2,081,781,370 | 7 / 7 |
| 2026-07-27 | $8.76 | $2,081,805,288 | 4 / 6 |
| 2026-07-28 | $8.76 | $2,081,805,288 | 4 / 6 |
| 2026-07-29 | $8.76 | $2,081,781,370 | 7 / 7 |
| 2026-07-30 | $8.76 | $2,081,781,370 | 7 / 7 |
| 2026-07-31 | $8.76 | $2,081,781,370 | 7 / 7 |
| 2026-08-01 | $8.76 | $2,081,805,288 | 4 / 6 |
| 2026-08-02 | $8.76 | $2,081,781,370 | 7 / 7 |
| 2026-08-03 | $8.98 | $2,087,624,230 | 7 / 7 |
| 2026-08-04 | $8.98 | $2,087,624,230 | 7 / 7 |
| 2026-08-05 | $9.25 | $2,096,938,510 | 7 / 7 |
| 2026-08-06 | $8.98 | $2,087,641,095 | 5 / 6 |
| 2026-08-07 | $8.98 | $2,087,641,095 | 5 / 6 |
| 2026-08-08 | $9.30 | $2,101,224,230 | 7 / 7 |
| 2026-08-09 | $8.98 | $2,087,641,095 | 5 / 6 |
| 2026-08-10 | $9.30 | $2,101,224,230 | 7 / 7 |
| 2026-08-12 | $8.98 | $2,087,641,095 | 5 / 6 |
| 2026-08-13 | $8.98 | $2,087,641,095 | 5 / 6 |
| 2026-08-14 | $8.98 | $2,087,641,095 | 5 / 6 |
| 2026-08-15 | $8.98 | $2,087,641,095 | 5 / 6 |
| 2026-08-16 | $8.98 | $2,087,641,095 | 5 / 6 |
| 2026-08-17 | $8.98 | $2,087,641,095 | 5 / 6 |
| 2026-08-18 | $8.98 | $2,087,641,095 | 5 / 6 |
| 2026-08-19 | $8.98 | $2,087,641,095 | 5 / 6 |
| 2026-08-20 | $9.41 | $2,115,614,286 | 5 / 6 |
| 2026-08-21 | $9.41 | $2,115,614,286 | 5 / 6 |
| 2026-08-22 | $9.41 | $2,115,614,286 | 5 / 6 |
| 2026-08-23 | $9.41 | $2,115,614,286 | 5 / 6 |
| 2026-08-24 | $9.41 | $2,115,614,286 | 5 / 6 |
| 2026-08-25 | $9.41 | $2,115,614,286 | 5 / 6 |
| 2026-08-26 | $9.51 | $2,124,471,429 | 5 / 6 |
| 2026-08-27 | $9.51 | $2,124,471,429 | 5 / 6 |
| 2026-08-28 | $9.51 | $2,124,471,429 | 5 / 6 |
| 2026-08-29 | $9.51 | $2,124,471,429 | 5 / 6 |
| 2026-08-30 | $9.51 | $2,124,471,429 | 5 / 6 |
| 2026-08-31 | $9.51 | $2,124,471,429 | 5 / 6 |
| 2026-09-01 | $9.51 | $2,124,471,429 | 5 / 6 |
| 2026-09-02 | $9.51 | $2,124,471,429 | 5 / 6 |
| 2026-09-03 | $9.51 | $2,124,471,429 | 5 / 6 |
| 2026-09-04 | $9.51 | $2,124,471,429 | 5 / 6 |
| 2026-09-05 | $9.51 | $2,124,471,429 | 5 / 6 |
| 2026-09-06 | $9.51 | $2,124,471,429 | 5 / 6 |
| 2026-09-07 | $9.51 | $2,124,471,429 | 5 / 6 |
| 2026-09-08 | $9.51 | $2,124,471,429 | 5 / 6 |
| 2026-09-09 | $9.51 | $2,124,471,429 | 5 / 6 |
| 2026-09-10 | $9.51 | $2,124,471,429 | 5 / 6 |
| 2026-09-11 | $9.51 | $2,124,471,429 | 5 / 6 |
| 2026-09-12 | $9.51 | $2,124,471,429 | 5 / 6 |
| 2026-09-13 | $9.51 | $2,124,471,429 | 5 / 6 |
| 2026-09-14 | $9.51 | $2,124,471,429 | 5 / 6 |
| 2026-09-15 | $9.51 | $2,124,471,429 | 5 / 6 |
| 2026-09-16 | $9.51 | $2,124,471,429 | 5 / 6 |
| 2026-09-17 | $9.51 | $2,124,471,429 | 5 / 6 |
| 2026-09-18 | $9.51 | $2,124,471,429 | 5 / 6 |
| 2026-09-19 | $9.51 | $2,124,471,429 | 5 / 6 |
| 2026-09-20 | $9.51 | $2,124,471,429 | 5 / 6 |
| 2026-09-21 | $9.51 | $2,124,471,429 | 5 / 6 |
| 2026-09-22 | $9.51 | $2,124,471,429 | 5 / 6 |
| 2026-09-23 | $9.51 | $2,124,471,429 | 5 / 6 |
| 2026-09-24 | $9.51 | $2,124,471,429 | 5 / 6 |
| 2026-09-25 | $9.51 | $2,124,471,429 | 5 / 6 |
| 2026-09-26 | $9.51 | $2,124,471,429 | 5 / 6 |
| 2026-09-27 | $9.51 | $2,124,471,429 | 5 / 6 |
| 2026-09-28 | $9.51 | $2,124,471,429 | 5 / 6 |
| 2026-09-29 | $9.51 | $2,124,471,429 | 5 / 6 |
| 2026-09-30 | $9.51 | $2,124,471,429 | 5 / 6 |
| 2026-10-01 | $9.53 | $2,124,471,429 | 5 / 6 |
| 2026-10-02 | $9.53 | $2,124,471,429 | 5 / 6 |
| 2026-10-03 | $9.53 | $2,124,471,429 | 5 / 6 |
| 2026-10-04 | $9.53 | $2,124,471,429 | 5 / 6 |
| 2026-10-05 | $9.53 | $2,124,471,429 | 5 / 6 |
| 2026-10-06 | $9.53 | $2,124,471,429 | 5 / 6 |
| 2026-10-07 | $9.53 | $2,124,471,429 | 5 / 6 |
| 2026-10-08 | $9.53 | $2,124,471,429 | 5 / 6 |
| 2026-10-09 | $9.53 | $2,124,471,429 | 5 / 6 |
| 2026-10-10 | $9.53 | $2,124,471,429 | 5 / 6 |
| 2026-10-11 | $9.53 | $2,124,471,429 | 5 / 6 |
| 2026-10-12 | $9.53 | $2,124,471,429 | 5 / 6 |
| 2026-10-13 | $9.53 | $2,124,471,429 | 5 / 6 |
| 2026-10-14 | $9.53 | $2,124,471,429 | 5 / 6 |
| 2026-10-15 | $9.53 | $2,124,471,429 | 5 / 6 |
| 2026-10-16 | $9.56 | $2,126,914,286 | 5 / 6 |
| 2026-10-17 | $9.56 | $2,126,914,286 | 5 / 6 |
| 2026-10-18 | $9.56 | $2,126,914,286 | 5 / 6 |
| 2026-10-19 | $9.56 | $2,126,914,286 | 5 / 6 |
| 2026-10-20 | $9.56 | $2,126,914,286 | 5 / 6 |
| 2026-10-21 | $9.56 | $2,126,985,714 | 5 / 6 |
| 2026-10-22 | $9.56 | $2,126,985,714 | 5 / 6 |
| 2026-10-23 | $9.56 | $2,126,985,714 | 5 / 6 |
| 2026-10-24 | $9.56 | $2,126,985,714 | 5 / 6 |
| 2026-10-25 | $9.56 | $2,126,985,714 | 5 / 6 |
| 2026-10-26 | $9.56 | $2,126,985,714 | 5 / 6 |
| 2026-10-27 | $9.56 | $2,126,985,714 | 5 / 6 |
| 2026-10-28 | $9.56 | $2,126,985,714 | 5 / 6 |
| 2026-10-29 | $9.56 | $2,126,985,714 | 5 / 6 |
| 2026-10-30 | $9.56 | $2,126,985,714 | 5 / 6 |
| 2026-10-31 | $9.49 | $2,128,893,430 | 5 / 6 |
| 2026-11-01 | $9.47 | $2,135,750,572 | 5 / 6 |
| 2026-11-02 | $9.47 | $2,135,750,572 | 5 / 6 |
| 2026-11-03 | $9.45 | $2,145,671,429 | 5 / 6 |
| 2026-11-04 | $9.51 | $2,149,957,143 | 5 / 6 |
Revenue and EPS estimates track expectations. They are not delivered results or like-for-like proof of a required annual path.
Latest: 7 Buy / Strong Buy · 0 Hold · 0 Sell / Strong Sell
Recent actions · Oct 6–Nov 4 · 3 recorded
1 raises · 0 cuts · 0 unchanged · 0 without a comparable prior
Oct 6, 2026–Nov 4, 2026. Each firm's latest positive target is paired only with its immediately prior positive target from the same provider, at most 180 days earlier. Unmatched observations have one dot; conflicting observations are not compared.
Look for updated results and guidance against the published targets, plus direct evidence for unresolved drivers.
3 of 3 published conditions remain under pressure or need verification. The next results need to address those conditions.
The dated weekly assessment and its assumptions are available in Read detailed Outlook.